Sequoia Financial Advisors LLC Acquires New Stake in Acadia Healthcare Company, Inc. $ACHC

Sequoia Financial Advisors LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 14,742 shares of the company’s stock, valued at approximately $345,000.

Several other institutional investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN boosted its stake in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $52,000. GAMMA Investing LLC increased its stake in Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after buying an additional 2,698 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after buying an additional 5,203 shares in the last quarter.

Analysts Set New Price Targets

Several equities analysts have commented on ACHC shares. TD Cowen raised their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Barclays increased their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Royal Bank Of Canada lifted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Finally, Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $28.69.

Acadia Healthcare Stock Down 2.3%

Shares of NASDAQ:ACHC opened at $34.78 on Thursday. The firm has a 50 day simple moving average of $27.32 and a 200-day simple moving average of $22.96. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market capitalization of $3.20 billion, a PE ratio of -2.84, a P/E/G ratio of 11.88 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The firm had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same period last year, the firm posted $0.40 EPS. The company’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.